154 related articles for article (PubMed ID: 34488901)
1. Public and decision-maker stated preferences for pharmaceutical subsidy decisions in Iran: an application of the discrete choice experiment.
Afsharmanesh G; Rahimi F; Zarei L; Peiravian F; Mehralian G
J Pharm Policy Pract; 2021 Sep; 14(1):74. PubMed ID: 34488901
[TBL] [Abstract][Full Text] [Related]
2. Eliciting the public preferences for pharmaceutical subsidy in Iran: a discrete choice experiment study.
Delpasand M; Olyaaeemanesh A; Jaafaripooyan E; Abdollahiasl A; Davari M; Kazemi Karyani A
J Pharm Policy Pract; 2021 Jul; 14(1):59. PubMed ID: 34256875
[TBL] [Abstract][Full Text] [Related]
3. Using a stated preference discrete choice experiment to assess societal value from the perspective of decision-makers in Europe. Does it work for rare diseases?
López-Bastida J; Ramos-Goñi JM; Aranda-Reneo I; Trapero-Bertran M; Kanavos P; Rodriguez Martin B
Health Policy; 2019 Feb; 123(2):152-158. PubMed ID: 30528244
[TBL] [Abstract][Full Text] [Related]
4. Public and decision maker stated preferences for pharmaceutical subsidy decisions: a pilot study.
Whitty JA; Scuffham PA; Rundle-Thiele SR
Appl Health Econ Health Policy; 2011 Mar; 9(2):73-9. PubMed ID: 21332251
[TBL] [Abstract][Full Text] [Related]
5. Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics.
Mühlbacher AC; Sadler A; Jordan Y
Eur J Health Econ; 2022 Dec; 23(9):1483-1496. PubMed ID: 35138495
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries.
Baji P; García-Goñi M; Gulácsi L; Mentzakis E; Paolucci F
Eur J Health Econ; 2016 Sep; 17(7):791-9. PubMed ID: 26296623
[TBL] [Abstract][Full Text] [Related]
7. Australian Public Preferences for the Funding of New Health Technologies: A Comparison of Discrete Choice and Profile Case Best-Worst Scaling Methods.
Whitty JA; Ratcliffe J; Chen G; Scuffham PA
Med Decis Making; 2014 Jul; 34(5):638-54. PubMed ID: 24713695
[TBL] [Abstract][Full Text] [Related]
8. Attributes Development for Pharmaceutical Subsidization: A Qualitative Study.
Afsharmanesh G; Mehralian G; Peiravian F
Iran J Pharm Res; 2020; 19(1):203-217. PubMed ID: 32922481
[TBL] [Abstract][Full Text] [Related]
9. Patient preferences for heart valve disease intervention.
Fifer S; Keen B; Guilbert-Wright P; Yamabe K; Murdoch DJ
Health Expect; 2023 Dec; 27(1):. PubMed ID: 38050462
[TBL] [Abstract][Full Text] [Related]
10. Quantifying benefit-risk preferences for medical interventions: an overview of a growing empirical literature.
Brett Hauber A; Fairchild AO; Reed Johnson F
Appl Health Econ Health Policy; 2013 Aug; 11(4):319-29. PubMed ID: 23637054
[TBL] [Abstract][Full Text] [Related]
11. Using a stated preference discrete choice experiment to assess societal value from the perspective of patients with rare diseases in Italy.
López-Bastida J; Ramos-Goñi JM; Aranda-Reneo I; Taruscio D; Magrelli A; Kanavos P
Orphanet J Rare Dis; 2019 Jun; 14(1):154. PubMed ID: 31242905
[TBL] [Abstract][Full Text] [Related]
12. What Do Patients Want from Otolaryngologists? A Discrete Choice Experiment.
Naunheim MR; Rathi VK; Naunheim ML; Alkire BC; Lam AC; Song PC; Shrime MG
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):618-624. PubMed ID: 28675119
[TBL] [Abstract][Full Text] [Related]
13. Insights from triangulation of two purchase choice elicitation methods to predict social decision making in healthcare.
Whitty JA; Rundle-Thiele SR; Scuffham PA
Appl Health Econ Health Policy; 2012 Mar; 10(2):113-26. PubMed ID: 22201266
[TBL] [Abstract][Full Text] [Related]
14. Job preferences for healthcare administration students in China: A discrete choice experiment.
Liu S; Li S; Li Y; Wang H; Zhao J; Chen G
PLoS One; 2019; 14(1):e0211345. PubMed ID: 30682170
[TBL] [Abstract][Full Text] [Related]
15. Do Profit Margins of Pharmaceuticals Influence Reimbursement Decisions? A Discrete Choice Experiment Among Dutch Healthcare Decision Makers.
Enzing JJ; Himmler S; Knies S; Brouwer WBF
Value Health; 2022 Feb; 25(2):222-229. PubMed ID: 35094795
[TBL] [Abstract][Full Text] [Related]
16. Investigating patients' preferences for new anti-diabetic drugs to inform public health insurance coverage decisions: a discrete choice experiment in China.
Geng J; Bao H; Feng Z; Meng J; Yu X; Yu H
BMC Public Health; 2022 Oct; 22(1):1860. PubMed ID: 36199056
[TBL] [Abstract][Full Text] [Related]
17. Patient preferences and shared decision making for the traditional Chinese medicine treatment of lung cancer: A discrete choice experiment study.
Teng Y; Wei Y; Chen Y; Yan J; Liu S; Li F; Bao S; Ren Y; Liu L; Yang Y
Integr Med Res; 2023 Sep; 12(3):100969. PubMed ID: 37546234
[TBL] [Abstract][Full Text] [Related]
18. Public preferences for the allocation of donor organs for transplantation: A discrete choice experiment.
Oedingen C; Bartling T; Schrem H; Mühlbacher AC; Krauth C
Soc Sci Med; 2021 Oct; 287():114360. PubMed ID: 34507218
[TBL] [Abstract][Full Text] [Related]
19. Decision-making criteria among national policymakers in five countries: a discrete choice experiment eliciting relative preferences for equity and efficiency.
Mirelman A; Mentzakis E; Kinter E; Paolucci F; Fordham R; Ozawa S; Ferraz M; Baltussen R; Niessen LW
Value Health; 2012 May; 15(3):534-9. PubMed ID: 22583464
[TBL] [Abstract][Full Text] [Related]
20. Patient and Public Acceptance of Digital Technologies in Health Care: Protocol for a Discrete Choice Experiment.
Fischer AK; Mühlbacher AC
JMIR Res Protoc; 2023 Aug; 12():e46056. PubMed ID: 37561559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
